A pediatric patient presents to the emergency department with complaints of shortness of breath, increased work of breathing, and a cough. The patient is alert and oriented at times 3, skin is pink, warm and dry. BP 112/68, T99, P106, RR 32. pulse oximetry 90% on room air. Assessment of the lung sounds reveals diminished lung sounds throughout all lung fields. The patient has a past medical history of peanut allergy. The mother tells you that they were at a birthday party and after consumption of a cupcake, the symptoms started. The nurse anticipates that which of the following medications will likely be ordered for this patient?

A. Replacement therapy with pancreatic enzymes: Pancreatic insufficiency results in a lack of digestive enzymes, leading to malabsorption of nutrients. Enzyme replacement therapy is essential to aid in digestion and nutrient absorption.
B. Treatment with stimulant laxatives: Stimulant laxatives are used to treat constipation by increasing bowel motility. They do not address the underlying enzyme deficiency in pancreatic insufficiency and can potentially cause further nutrient loss.
C. Treatment with PPIs to decrease stomach acid: Proton pump inhibitors (PPIs) reduce stomach acid production and are used for conditions like GERD. They do not address the enzyme deficiency caused by pancreatic insufficiency.
D. Decrease food intake: Reducing food intake does not treat pancreatic insufficiency and can lead to malnutrition. The goal is to support normal digestion and nutrient absorption through enzyme replacement.

A. Antacids: Antacids are generally used to neutralize stomach acid and can provide symptomatic relief for peptic ulcer disease (PUD). They are not typically contraindicated and can be part of the treatment regimen, although they do not address the underlying cause of PUD.
B. NSAIDs: Nonsteroidal anti-inflammatory drugs (NSAIDs) are known to irritate the gastric mucosa and can exacerbate or cause peptic ulcers by inhibiting the production of protective prostaglandins in the stomach lining. Patients with peptic ulcer disease should avoid NSAIDs to prevent further irritation and ulcer formation.
C. PPIs: Proton pump inhibitors (PPIs) are commonly prescribed to reduce gastric acid secretion and promote ulcer healing in peptic ulcer disease. They are a key component of the treatment regimen and not to be avoided unless there are specific contraindications.
D. H2-receptor blockers: H2-receptor blockers reduce stomach acid production and are used to treat and prevent peptic ulcers. They are an important part of the management strategy for PUD and are not typically contraindicated.